Webcast is Live on Tuesday, February 24, at 10 a.m. (ET)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb. 19, 2015--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that Gary Maharaj, president and chief
executive officer, will make a presentation to the investment community
at the RBC Capital Markets Global Healthcare Conference on Tuesday,
February 24, 2015, at 10 a.m. ET (9 a.m. CT) in New York City.
A live audio webcast of the presentation will be available by going to
the investor relations portion of the Company’s website at www.surmodics.com
and clicking on the webcast icon. An audio replay will be available
beginning at 10:30 a.m. CT on Tuesday, February 24, and is accessible
for 90 days.
About SurModics, Inc.
SurModics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed to
improve lives by enabling the detection and treatment of disease. Our
mission is to be a trusted partner to our customers by providing the
most advanced surface modification technologies and in vitro
diagnostic chemical components that help enhance the well-being of
patients. The company’s core offerings include surface modification
coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro
diagnostic test kits and microarrays. SurModics’ strategy is to build on
the product and technical leadership within these fields, and expand the
core offerings to generate opportunities for longer term sustained
growth. SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
